Thompson Investment Management Inc. Has $346,000 Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Thompson Investment Management Inc. reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 42.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,000 shares of the company's stock after selling 3,725 shares during the period. Thompson Investment Management Inc.'s holdings in Henry Schein were worth $346,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Cromwell Holdings LLC lifted its stake in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. City State Bank bought a new position in shares of Henry Schein in the 4th quarter valued at $55,000. Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after acquiring an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Up 0.5 %

Henry Schein stock traded up $0.42 during trading hours on Thursday, reaching $77.62. 1,507,784 shares of the company's stock were exchanged, compared to its average volume of 1,444,106. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm's 50 day simple moving average is $73.85 and its 200 day simple moving average is $71.93. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The firm has a market capitalization of $9.68 billion, a PE ratio of 31.94, a PEG ratio of 2.21 and a beta of 0.91.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of research reports. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Barrington Research increased their price target on Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research note on Thursday, January 30th. Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target for the company. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and increased their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $80.10.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.